Application and Research Progress of Glucosamine in Health Food

CHI Hailin; LI Feifei; ZHANG Liwei; JIANG Yu

doi:10.13386/j.issn1002-0306.2022050211

Volume 44 Issue 8

Apr. 2023

Turn off MathJax

Article Contents

Abstract

References

Science and Technology of Food Industry > 2023 > 44(8): 437-445. > DOI: 10.13386/j.issn1002-0306.2022050211

CHI Hailin, LI Feifei, ZHANG Liwei, et al. Application and Research Progress of Glucosamine in Health Food[J]. Science and Technology of Food Industry, 2023, 44(8): 437−445. (in Chinese with English abstract). doi: 10.13386/j.issn1002-0306.2022050211.

Citation:

PDF (1313 KB)

Application and Research Progress of Glucosamine in Health Food

Center for Food Evaluation, State Administration for Market Regulation, Beijing 100070, China

More Information

Received Date: May 18, 2022
Available Online: February 08, 2023

Graphical Abstract

Abstract

Abstract

An aging society is coming in China with more and more serious problems such as osteoporosis and osteoarthritis. Glucosamine is one of important components from proteoglycan in human articular cartilage matrix, which can improve articular cartilage metabolism and promote bone and joint health. Commercially available glucosamine usually exists in the form of glucosamine hydrochloride, glucosamine sulfate and their double salts, and produced through acid and enzymatic hydrolysis and fermentation. Clinical studies have shown that it has high safety with no serious adverse reactions found and exhibits the health functions of promoting bone and joint health, antioxidation, regulating immunity, resisting bacteria and inflammation, etc. In health food, research in glucosamine is often focused on promoting bone health. In this article, the health functions, preparation techniques, safety and use of glucosamine are reviewed, while suggestions are given to improve the quality standard and production techniques due to no specific quality standard and standardized production process of glucosamine currently available, aiming at providing a reference for the development, supervision and regulation of glucosamine-based health foods.
- glucosamine,
- bone health,
- health food,
- registration management

FullText(HTML)

References (70)

References

[1]	KWATRA B. Collagen supplementation: Therapy for the prevention and treatment of osteoporosis and osteoarthritis: A review[J]. World Journal of Pharmacy and Pharmaceutical Sciences,2020,9(5):589−604.
[2]	TANTIKANLAYAPORN D, WICHIT P, SUKSEN K, et al. Andrographolide modulates OPG/RANKL axis to promote osteoblastic differentiation in MC3T3-E1 cells and protects bone loss during estrogen deficiency in rats[J]. Biomedicine & Pharmacotherapy,2020,131:110763.
[3]	AMIRYAGHOUBI N, FATHI M, PESYAN N N, et al. Bioactive polymeric scaffolds for osteogenic repair and bone regenerative medicine[J]. Medicinal Research Reviews,2020,40(5):1833−1870. doi: 10.1002/med.21672
[4]	李哲, 蒋志雯, 张伟, 等. 氨基葡萄糖对绝经后骨质疏松模型大鼠的保护作用[J]. 中国海洋药物,2017,36(4):29−34. [LI Zhe, JIANG Zhiwen, ZHANG Wei, et al. Protective effect of glucosamine on postmenopausal osteoporosis model rats[J]. China Ocean Medicine,2017,36(4):29−34.
[5]	尹友红, 夏新兴. 氨基葡萄糖各制剂剂型对实验动物骨密度的研究[J]. 科技资讯,2017,15(26):177−178. [YIN Youhong, XIA Xinxing. Study on bone density of experimental animals by various formulations of glucosamine[J]. Science and Technology Information,2017,15(26):177−178.
[6]	刘慧娜. 盐酸氨基葡萄糖对不同时期骨关节炎患者TNF-α、IL-1β以及PGE-2的影响[J]. 中国医药导刊,2018,20(1):24−27. [LIU Huina. Effects of glucosamine hydrochloride on TNF-α, IL-1β and PGE-2 in patients with osteoarthritis at different stages[J]. China Medical Journal,2018,20(1):24−27.
[7]	邱贵兴, 翁习生, 张克, 等. 盐酸/硫酸氨基葡萄糖治疗骨关节炎的平行对照临床研究[J]. 中华医学杂志,2005(43):49−52. [QIU Guixing, WENG Xisheng, ZHANG Ke, et al. A parallel controlled clinical study of hydrochloric acid/glucosamine sulfate in the treatment of osteoarthritis[J]. Chinese Journal of Medicine,2005(43):49−52.
[8]	张百挡, 梁祖建, 张还添, 等. 盐酸/硫酸氨基葡萄糖治疗膝骨关节炎的成本效果分析[J]. 中国组织工程研究,2012,16(52):9867−9872. [ZHANG Baidang, LIANG Zujian, ZHANG Huantian, et al. Cost-effectiveness analysis of hydrochloric acid/glucosamine sulfate in the treatment of knee osteoarthritis[J]. Chinese Tissue Engineering Research,2012,16(52):9867−9872.
[9]	张伟滨, 庄澄宇, 李建民, 等. 盐酸氨基葡萄糖治疗骨性关节炎有效性与安全性评价[J]. 中华外科杂志,2007,45(14):998−1001. [ZHANG Weibin, ZHUANG Chengyu, LI Jianmin, et al. Evaluation of the efficacy and safety of glucosamine hydrochloride in the treatment of osteoarthritis[J]. Chinese Journal of Surgery,2007,45(14):998−1001.
[10]	SONG N, QI Q, CAO R, et al. MAVS O-GlcNAcylation is essential for host antiviral immunity against lethal RNA viruses[J]. Cell Reports,2019,28(9):2386−2396. doi: 10.1016/j.celrep.2019.07.085
[11]	曹秀明, 李惠, 刘万顺, 等. D-氨基葡萄糖盐酸盐抗肿瘤及其免疫调节作用机理的研究[A].中国工程院医药卫生学部, 中国抗癌协会抗癌药物专业委员会, 中国药理学会肿瘤药理专业委员会. 2007医学前沿论坛暨第十届全国肿瘤药理与化疗学术会议论文集[C]//青岛: 2007医学前沿论坛暨第十届全国肿瘤药理与化疗学术会议, 2007: 184[CAO Xiuming, LI Hui, LIU Wanshun, et al. Study on anti-tumor and immunomodulatory mechanism of D-glucosamine hydrochloride[A]. Chinese Academy of Engineering Department of Medicine and Health, Chinese Anti-Cancer Association Anti-cancer Drug Professional Committee, Chinese Pharmacological Society Oncology Pharmacology Professional Committee. 2007 Medical Frontier Forum and Proceedings of the 10th National Academic Conference on Cancer Pharmacology and Chemotherapy[C]//Qingdao: 2007 Medical Frontier Forum and Proceedings of the 10th National Academic Conference on Cancer Pharmacology and Chemotherapy, 2007: 184.]
[12]	戴关海, 江克翊, 徐庆乐, 等. 硫酸软骨素和氨基葡萄糖对小鼠免疫功能的影响[J]. 现代中药研究与实践,2006(2):36−38. [DAI Guanhai, JIANG Keyi, XU Qingle, et al. Effects of chondroitin sulfate and glucosamine on the immune function of mice[J]. Research and Practice of Modern Chinese Medicine,2006(2):36−38.
[13]	陈冠敏, 陈润, 张荣标, 等. 硫酸氨基葡萄糖对正常小鼠免疫功能的影响[J]. 卫生研究,2011,40(2):227−229. [CHEN Guanmin, CHEN Run, ZHANG Rongbiao, et al. Effects of glucosamine sulfate on immune function in normal mice[J]. Health Research,2011,40(2):227−229.
[14]	RAHIMIAN R, LALANCETTE-HÉBERT M, WENG Y C, et al. Glucosamine-mediated immunomodulation after stroke is sexually dimorphic[J]. Brain, Behavior, & Immunity-Health,2020,3:100041.
[15]	BASIRI F, RAD A, MAHDIAN D, et al. Effects of glucosamine against morphine-induced antinociceptive tolerance and dependence in mice[J]. Journal of Biomedical Science,2019,26(1):21. doi: 10.1186/s12929-019-0513-1
[16]	MCCARTY M F, ASSANGA S, LL LUJÁN, et al. Nutraceutical strategies for suppressing NLRP3 inflammasome activation: Pertinence to the management of COVID-19 and beyond[J]. Nutrients,2020,13(1):47. doi: 10.3390/nu13010047
[17]	CHIN K Y, AL-SAADI H M, PANG K L, et al. Multifaceted protective role of glucosamine against osteoarthritis: Review of its molecular mechanisms[J]. Scientia Pharmaceutica,2019,87(4):34. doi: 10.3390/scipharm87040034
[18]	杨艳. 壳寡糖, 氨基葡萄糖及其衍生物的抗氧化功能研究[D]. 青岛: 中国海洋大学, 2005 YANG Yan. Study on the antioxidant function of chitosan oligosaccharides, glucosamine and their derivatives [D]. Qingdao: Ocean University of China, 2005.
[19]	CHIU H W, LI L H, HSIEH C Y, et al. Glucosamine inhibits IL-1β expression by preserving mitochondrial integrity and disrupting assembly of the NLRP3 inflammasome[J]. Scientific Reports,2019,9(1):5603. doi: 10.1038/s41598-019-42130-z
[20]	MENDIS E, KIM M M, RAJAPAKSE N, et al. Sulfated glucosamine inhibits oxidation of biomolecules in cells via a mechanism involving intracellular free radical scavenging[J]. European Journal of Pharmacology,2008,579(1-3):74−85. doi: 10.1016/j.ejphar.2007.10.027
[21]	张莉, 刘万顺, 韩宝芹. D-氨基葡萄糖及其衍生物抗肿瘤活性的初步研究[J]. 中国海洋药物,2006(2):26−31. [ZHANG Li, LIU Wanshun, HAN Baoqin. A preliminary study on the antitumor activity of D-glucosamine and its derivatives[J]. China Ocean Medicine,2006(2):26−31.
[22]	LIU C Y, MENG J, ZHANG W Y. Effect of glucosamine on blood-brain barrier function during experimental autoimmune encephalomyelitis in rats[J]. Chinese Journal of Natural Medicine, 2008.
[23]	YOSHIMURA J, FUNABASHI M, ISHIGE S, et al. Studies on D-glucosamine derivatives. XII. The synthesis of N-Acetyi-3-O- and -4-O-aminoacyl-D-glucosamines[J]. Bulletin of the Chemical Society of Japan,2006,39(8):1760−1764.
[24]	SAENGNIPANTHKUL S, WAIKAKUL S, ROJANASTHIEN S, et al. Differentiation of patented crystalline glucosamine sulfate from other glucosamine preparations will optimize osteoarthritis treatment[J]. International Journal of Rheumatic Diseases,2019,22:376−385. doi: 10.1111/1756-185X.13068
[25]	DING Z Z, FENG X H, CHAO Z, et al. Secondary conversion of citric acid fermentation residue and edible fungi residue to produce glucosamine[J]. Biological Chemical Engineering,2018,1:280.
[26]	邓琛. 代谢调控谷氨酸棒杆菌合成乙酰氨基葡萄糖[D]. 无锡: 江南大学, 2021 DENG Chen. Metabolic regulation of acetylglucosamine synthesis by Corynebacterium glutamicum[D]. Wuxi: Jiangnan University, 2021.
[27]	KRAISANGSRI J, NALINANON S, RIEBROY S, et al. Physicochemical characteristics of glucosamine from blue swimming crab (Portunus pelagicus) shell prepared by acid hydrolysis[J]. Walailak Journal of Science and Technology (WJST),2018,15(12):869−877.
[28]	张健. 一种硫酸氨基葡萄糖氯化钠复盐的合成方法: 中国, 110903330A[P]. 2020-03-24 ZHANG Jian. A kind of synthetic method of glucosamine sulfate sodium chloride double salt: China, 110903330A[P]. 2020-03-24.
[29]	孙丽. 虾头制备盐酸氨基葡萄糖的优化研究[J]. 福建分析测试,2018,27(3):15−19. [SUN Li. Optimization study on the preparation of glucosamine hydrochloride from shrimp heads[J]. Fujian Analysis and Testing,2018,27(3):15−19.
[30]	韩立路. 贝壳制备氨基葡萄糖盐酸盐影响因素的探讨[J]. 中国科技信息,2009(376):232−233. [HAN Lilu. Discussion on influencing factors of shell preparation of glucosamine hydrochloride[J]. China Science and Technology Information,2009(376):232−233.
[31]	林秀芬, 孙丽, 石国宗. 一种硫酸氨基葡萄糖的制备方法: 福建省, 101343294B[P]. 2011-04-27 LIN Xiufen, SUN Li, SHI Guozong. A preparation method of glucosamine sulfate: Fujian Province, 101343294B[P]. 2011-04-27.
[32]	ROVATI L. Pharmaceutically active glucosamine salts useful in the treatment of osteoarthritis and rheumatoid arthritis: US3683076a[P]. 1972.
[33]	SCHLECK, JAMES R, BURGER, et al. Glucosamine sulfate calcium chloride composition and processes for the preparation of glucosamine sulfate metal chlorides: United States, 6472380[P]. 2002-10-29.
[34]	尹鸿萍, 王莹, 聂煜, 等. 快速、高效的硫酸氨基葡萄糖氯化钾复盐制备: 中国, 102167714A[P]. 2011-08-31 YIN Hongping, WANG Ying, NIE Yu, et al. Rapid and efficient preparation of glucosamine sulfate potassium chloride double salt: China, 102167714A[P]. 2011-08-31.
[35]	吴东慧. 盐酸氨基葡萄糖含量测定方法研究现状[J]. 中国标准化,2018(2):3. [WU Donghui. Research status of methods for determination of glucosamine hydrochloride[J]. Standardization in China,2018(2):3.
[36]	邢荣娥, 李鹏程, 刘松, 等. 一种氨基葡萄糖盐酸盐制备新方法: 中国, 108003200A[P]. 2018-05-08 XING Rong'e, LI Pengcheng, LIU Song, et al. A new method for the preparation of glucosamine hydrochloride: China, 108003200A[P]. 2018-05-08.
[37]	SUN L. Method for producing n-acetyl-d-glucosamine and/or d-glucosamine salt by microbial fermentation: U. S. Patent Application 16/091, 865[P]. 2020-10-1.
[38]	程汝滨, 葛宇清, 方昀, 等. 一种氨基葡萄糖合成酶、工程菌及其应用: 中国, 108588049B[P]. 2021-05-14 CHENG Rubin, GE Yuqing, FANG Yun, et al. A glucosamine synthase, engineering bacteria and its application: China, 108588049B [P]. 2021-05-14.
[39]	WU Y, CHEN T, LIU Y, et al. CRISPRi allows optimal temporal control of N-acetylglucosamine bioproduction by a dynamic coordination of glucose and xylose metabolism in Bacillus subtilis[J]. Metabolic Engineering,2018,49:232−241. doi: 10.1016/j.ymben.2018.08.012
[40]	徐恒德, 于有良, 张西进, 等. 大自然生物集团有限公司. 基于微生物发酵法生产氨基葡萄糖的新技术研发[Z]. 日照: 山东黄海科技创新研究院, 2020-11-28 XU Hengde, YU Youliang, ZHANG Xijin, et al. Nature Biology Group Co., Ltd., Shandong Nature Biotechnology Research Institute Co., Ltd. Research and development of new technology for the production of glucosamine based on microbial fermentation[Z]. Rizhao: Shandong Huanghai Science and Technology Innovation Research Institute, 2020-11-28.
[41]	ZHU, JIANG, XUEQIN, et al. Biocatalytic production of glucosamine from N-acetylglucosamine by diacetylchitobiose deacetylase[J]. Journal of Microbiology and Biotechnology,2018,28(11):1850−1858. doi: 10.4014/jmb.1805.05061
[42]	刘龙, 陈坚, 卢健行, 等. 一种高效生产N-乙酰氨基葡萄糖的大肠杆菌及其应用: 中国, 114574410A[P]. 2022-06-03 LIU Long, CHEN Jian, LU Jianxing, et al. An Escherichia coli for efficient production of N-acetylglucosamine and its application: China, 114574410A[P]. 2022-06-03.
[43]	卢健行, 韩宁, 吴祥舟, 等. 微生物发酵生产氨基葡萄糖硫酸钾盐的方法: 中国, 110846373A[P]. 2020-02-28 LU Jianxing, HAN Ning, WU Xiangzhou, et al. Method for the production of glucosamine sulfate potassium salt by microbial fermentation: China, 110846373A[P]. 2020-02-28.
[44]	LÜ Y, ZHENG F, QIU C, et al. Heterologous expression of a thermostable chitinase from Myxococcus xanthus and its application for high yield production of glucosamine from shrimp shell[J]. Foods,2021,10:2808. doi: 10.3390/foods10112808
[45]	鲍晶晶. 多酶偶联催化甲壳素制备功能性糖氨基葡萄糖[A]. 中国食品科学技术学会. 中国食品科学技术学会第十五届年会论文摘要集[C]//青岛: 中国食品科学技术学会第十五届年会, 2018: 2. BAO Jingjing. Multi-enzyme coupling catalyzed the preparation of functional sugar glucosamine from chitin[A]. Chinese Institute of Food Science and Technology. Collection of abstracts of the 15th annual meeting of China Institute of Food Science and Technology[C]//Qingdao: The 15th annual meeting of China Institute of Food Science and Technology, 2018: 2.
[46]	孙玉英, 张继泉, 王淑军. D-氨基葡萄糖酶法生产工艺优化[A]. 香港国际工业电子中心. 2011国际生物医学与工程会议论文集（ISBE 2011 V2）[C]//香港: 智能信息技术应用学会, 2011: 4. SUN Yuying, ZHANG Jiquan, WANG Shujun. Optimization of D-glucosamine enzymatic production process [A]. Hong Kong International Industrial Electronics Center. Proceedings of the 2011 International Conference on Biomedicine and Engineering (ISBE 2011 V2) [C]//Hong Kong: Intelligent Information Technology Application Society, 2011: 4.
[47]	彭楠, 梁运祥, 王林春. 一种酶法生产的氨基葡萄糖及其制备方法: 中国, 103865969A[P]. 2014-06-18 PENG Nan, LIANG Yunxiang, WANG Linchun. An enzymatically produced glucosamine and its preparation method: China, 103865969A[P]. 2014-06-18.
[48]	吴昊. 酶法制备N-乙酰氨基葡萄糖及催化机理的研究[D]. 合肥: 合肥工业大学, 2021 WU Hao. Enzymatic preparation of N-acetylglucosamine and its catalytic mechanism [D]. Hefei: Hefei University of Technology, 2021.
[49]	丁春华, 章文劼. 酶法生产氨基葡萄糖盐及其提纯方法: 中国, 111518857A[P]. 2020-08-11 DING Chunhua, ZHANG Wenjie. Enzymatic production of glucosamine salt and its purification method: China, 111518857A[P]. 2020-08-11.
[50]	LOMONTE A B V, MENDONÇA J A, BRANDÃO G C, et al. Multicenter, randomized, double-blind clinical trial to evaluate efficacy and safety of combined glucosamine sulfate and chondroitin sulfate capsules for treating knee osteoarthritis[J]. Advances in Rheumatology,2019:58.
[51]	WANDEL S. Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: Network meta-analysis[J]. BMJ: British Medical Journal,2010:341.
[52]	张静, 杨非, 颜燕. D-氨基葡萄糖盐酸盐的毒性研究[J]. 现代预防医学,2009,36(14):2713−2715, 2718. [ZHANG Jing, YANG Fei, YAN Yan. Toxicity study of D-glucosamine hydrochloride[J]. Modern Preventive Medicine,2009,36(14):2713−2715, 2718.
[53]	王大利, 耿成燕, 姜丽平, 等. 盐酸氨基葡萄糖经口重复给予大鼠28d的毒性试验[J]. 毒理学杂志,2011,25(1):77−78. [WANG Dali, GENG Chengyan, JIANG Liping, et al. Toxicity test of repeated oral administration of glucosamine hydrochloride to rats for 28 days[J]. Journal of Toxicology,2011,25(1):77−78.
[54]	张伟滨, 庄澄宇, 李建民, 等. 盐酸氨基葡萄糖治疗骨性关节炎有效性与安全性评价[J]. 中华外科杂志,2007,45(14):4. [ZHANG Weibin, ZHUANG Chengyu, LI Jianmin, et al. Efficacy and safety evaluation of glucosamine hydrochloride in the treatment of osteoarthritis[J]. Chinese Journal of Surgery,2007,45(14):4.
[55]	鲜平, 向元兵, 黄朝莉, 等. 盐酸氨基葡萄糖片治疗类风湿关节炎致膝软骨损伤的疗效观察[J]. 华西医学,2016,31(5):831−834. [XIAN Ping, XIANG Yuanbing, HUANG Chaoli, et al. Observation of curative effect of glucosamine hydrochloride tablets on knee cartilage damage caused by rheumatoid arthritis[J]. West China Medicine,2016,31(5):831−834.
[56]	AUTHORITY E. Scientific opinion on the safety of caffeine[J]. Efsa Journal,2016,13(5):4102.
[57]	国家食品药品监督管理局保健食品化妆品监管司. 关于征求《已使用保健食品原料名称目录（第二批）》（征求意见稿）意见的函. 食药监保化函[2012]322号[EB/OL]. [2012-07-06]http://www.chc.org.cn/news/detail.php?id=61094 Department of Health Food and Cosmetics Supervision, State Food and Drug Administration. Letter on Solicitation of Opinions on the Catalogue of the Names of Used Health Food Raw Materials (Second Batch) (Draft for Comments). Food and Drug Administration Baohuahan [2012] No. 322[EB/OL]. [2012-07-06]http://www.chc.org.cn/news/detail.php?id=61094
[58]	The United States Pharmacopeial Convention. United States Pharmacopoeia 40/National Formulary 35 [S]. Washington: The United States Pharmacopeial Convention, 2016.
[59]	European Food Safety Authority. Scientific opinion on the substantiation of a health claim related to glucosamine and maintenance of joints pursuant to Article 13(5) of Regulation (EC)No 1924/2006[J]. EFSA Journal,2011,9(12):2476. doi: 10.2903/j.efsa.2011.2476
[60]	European Food Safety Authority. Scientific opinion on the substantiation of a health claim related to glucosamine and maintenance of normal joint cartilage pursuant to Article 13 ( 5 ) of Regulation ( EC ) No 1924/2006[J]. EFSA Journal,2012,10(5):2691. doi: 10.2903/j.efsa.2012.2691
[61]	Health Canada. Glucosamine Hydrochloride [EB/OL]. （2008-12-19） [2022-4-19]. http://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq.do?atid=glucosamine.hydrochloride&lang=eng.
[62]	Health Canada. Glucosamine Sulfate [EB/OL]. （2022-04-09） [2022-4-19]. http://webprod.hc-sc.gc.ca/nhpid-bdipsn/atReq.do?atid=glucosamine.sulfate&lang=eng.
[63]	Parliamentary Secretary to the Minister for Health and Aged Care. Therapeutic Goods Act 1989[EB/OL]. （2000-03-22） [2022-4-19]. https://www.tga.gov.au/legislation-listing/therapeutic-goods-listing-notice-2000-no-1.
[64]	Information system on safety and effectiveness for health food. Glucosamine[EB/OL]. （2021-12-22） [2022-4-19]. https://hfnet.nibiohn.go.jp/contents/detail24.html#1.
[65]	MCCARTY M F, O'KEEFE J H, DINICOLANTONIO J J. Glucosamine for the treatment of osteoarthritis: The time has come for higher-dose trials[J]. Journal of Dietary Supplements,2019,16(2):179−192. doi: 10.1080/19390211.2018.1448920
[66]	WU D, HUANG Y, GU Y, et al. Efficacies of different preparations of glucosamine for the treatment of osteoarthritis: A meta-analysis of randomised, double-blind, placebo-controlled trials[J]. International Journal of Clinical Practice,2013,67(6):585−594. doi: 10.1111/ijcp.12115
[67]	张伟斌. 氨基葡萄糖治疗骨关节炎的专家共识[J]. 中华外科杂志,2008,46(18):1437−1438. [ZHANG Weibin. Expert consensus on glucosamine in the treatment of osteoarthritis[J]. Chinese Journal of Surgery,2008,46(18):1437−1438.
[68]	MENON B V V, HASHIM R, ZAINAL Z A, et al. The effect of glucosamine with or without chondroitin sulphate on glucose monitoring parameters in humans–a systematic review[J]. Journal of Young Pharmacists,2021,13(1):19. doi: 10.5530/jyp.2021.13.4
[69]	陈广东. 镇痛药早期干预对骨关节炎软骨下骨影响的实验研究[D]. 苏州: 苏州大学, 2019 CHEN Guangdong. An experimental study on the effect of analgesic early intervention on subchondral bone in osteoarthritis [D]. Suzhou: Soochow University, 2019.
[70]	ARTMANN D J, AMRAIN W, MURAUER A, et al. Critical evaluation of a putative glucosamine excretion by Aspergillus niger CBS120.49 and Penicillium ochrochloron CBS123.824 under citric acid producing conditions[J]. Scientific Reports,2019,9(1):1−9. doi: 10.1038/s41598-018-37186-2

Supplements (0)

Cited By

Get Citation

PDF

XML

Article Metrics

Article views (327) PDF downloads (72)

Science and Technology of Food Industry

Application and Research Progress of Glucosamine in Health Food

Abstract

References

Catalog

Article Metrics

Export File

Citation

Format

Content